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Abstract
Diabetes is a growing problem in the U.S.A., closely linked to the current obesity epidemic.
Two common complications of diabetes, osteomyelitis of the foot, and Charcot’s joint, are
impossible to differentiate via traditional Magnetic Resonance Imaging. The background of
Magnetic Resonance Spectroscopy, which transforms the time-domain MRI signal into the
frequency domain spectrum, is explored, and its use to aid in this differentiation is proposed.




Diabetes is a growing problem in the U.S.A. It is closely linked to the current obesity epi-
demic. The diabetic ulcer is an exceedingly common complication of advanced stages of this
disease. It is commonly associated with poor circulation, which, in combination with other
complications of diabetes, predisposes a patient to osteomyelitis of the foot. Another disease
commonly associated with diabetes is Charcot’s joint due to diabetic neuropathy. These
distinct processes have multiple overlapping Magnetic Resonance Imaging findings, which
often make differentiation of the two impossible via traditional MRI. Another study, such as
a nuclear scan, is typically required to differentiate the two processes.
In this research, the use of MR spectroscopy is proposed to differentiate the causes of
edema by detecting differences in metabolite levels within the bones of the foot, arthritides
and osteomyelitis. Because of their value in classification problems, this research will employ
neural networks to expedite this important detection.
1
2 Background
2.1 Magnetic Resonance Imaging
Magnetic Resonance Imaging is a medical imaging tool used in readiology to visualize internal
structures. It uses a powerful magnetic field to align the magnetization of some atoms in
the body, then applies radio frequency fields to systematically alter the alignment of this
magnetization. This induces the atoms’ nuclei to produce a rotating magnetic field, which
is recorded by the scanner, and then assembled to produce an image of the scanned area.
2.2 Magnetic Resonance Spectroscopy
Magnetic Resonance Spectroscopy (MRS) relies on the same basic techniques used in MRI.
The principle difference is the manner in which the acquired data is presented [26].
2.2.1 Frequency Domain
MRI uses a signal obtained in the time domain to generate an image. MRS uses the Fourier
transform of the MR signal, which is in the time domain to generate a frequency domain
spectrum of the components that comprise the image.
Figure 1 shows a T1-weighted spin echo image of a 10% ethanol solution. Figure 2 shows
the free induction decay process of the MR signal arising from the protons associated with
water and ethanol versus time; this is used to generated the image in Figure 1. The time
decay process is characterized by
I = e−kt/T
where I is the intensity of the signal at time t, k is a constant, and T is the relaxation time
of the nuclei being excited.
It is difficult to determine which part of the image in Figure 1 is composed of protons from
ethanol. However, a Fourier transformation of the time-domain signal results in a frequency
distribution of the proton components that make up the time domain signal (Figure 3). This
frequency spectrum reveals which part of the time domain signal arises from the protons of
the methyl (CH3) and which part is from the methylene (CH2) groups of ethanol.
Why, then, do the protons of water appear at different regions of the frequency domain
than those of the methyl and methylene groups of ethanol? Nuclear magnetic resonance
(NMR) is based on the principle that nuclei have an associated spin property, which causes
them to behave like small magnets [14, 26]. In the presence of a magnetic field, the nuclei
interact with the magnetic field, distributing themselves to different levels.
In the case of protons, which have a “spin quantum number” of 1
2
, the nuclei distribute
themselves into two distinct states, corresponding to their spin in either the direction of or the
direction opposite the applied magnetic field. The separation between levels is proportional
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Figure 1: T1-weighted spin echo image of a 10% ethanol solution.
Figure 2: The free induction decay (FID) process of 10% ethanol solution shown in Figure
1.
3
Figure 3: The Fourier transform of the FID shown in Figure 2.
to the strength of the applied magnetic field; as the magnetic field strength increases, so
does the intensity of the signal. This is partly the result of the increase in energy separation
between the two states, and partly becuase of the increase in the number of nuclei in a
lower-energy state that can be excited to a higher-energy state [14].
If energy is applied in the form of a radiofrequency wave that exactly matches the energy
separation between the two energy states, then a “resonance” occurs. Nuclei in the lower-
energy state absorb this resonance energy and are promoted to the higher-energy state. This
phenomenon is described by the Larmor frequency equation,
∆E = κω0 = κγB0 (1)
where ω0 is the Larmor precessional frequency (Hertz), κ is the Planck constant divided by
2π, γ is the gyromagnetic ratio for each nucleus (megahertz per Tesla), and B0 is the applied
magnetic field (Elsa).
2.2.2 Chemical Shift
The Larmor frequency equation (1) states that the resonance frequency of a magnetic nu-
clei (the radiofrequency necessary to excite a given nuclei) is directly proportional to the
magnetic field environment it experiences. Different atoms resonate at different Larmor ra-
diofrequencies because their nuclei have different magnetic spin properties. This is the basis
for the NMR phenomenon and allows the identification of magnetic nuclei with different
atomic numbers. However, even for another magnetic nuclei or atom with the same atomic
number, chemical compounds containing this nuclei may have slightly different Larmor res-
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onance frequencies. This results from the electrons that surround the nuclei, forming the
electron cloud.
Electrons are negatively charged, and, like protons and neutrons, also have spin proper-
ties. Thus, when placed in a magnetic field, electrons will produce a small magnetic field B′
around the nuclei. These local magnetic fields generated by the surrounding electrons can
add to or subtract from the applied field B0. Consequently, the nuclei experiences a slightly
different magnetic field Beff′ , which is equal to B0 −B. Because of this small change in the
local magnetic field, the nucleus will resonate with a slightly shifted Larmor frequency, since
the frequency is the product of the gyromagnetic ratio and the local magnetic field strength
experienced by the nucleus. This phenomenon is called the chemical shift and is the basis
for MRS.
This explains why the protons of ethanol (Figure 3) have different Larmor frequencies.
The molecular structure of ethanol is such that the hydrogen nuclei (protons) are found in
three different atomic groups in the molecule, and experiences the effects of three different
electron cloud distributions. The local magnetic field of these three positions differ slightly,
and each of these hydrogen nuclei resonates at a frequency characteristic of its position in the
molecule. Consequently, the proton spectrum of ethanol (Figure 3) depicts different resonate
frequencies: one for the CH3 protons; another for the CH2 protons.
2.2.3 Spin-Spin Scalar Coupling
The protons in the methyl group and methylene in ethanol are composed of three and four
resonate frequencies, respectively. This is the result of the quantum mechanical phenomenon
of spin-spin coupling or splitting. The observations of these frequency-splitting patterns
are explained by the magnetic field of one proton influenced by the arrangement of the
spin orientations of adjacent groups. Nuclei with a net spin quantum number of 1
2
in the
direction of the applied magnetic field or in a direction 180◦ opposed to it are affected. For
the three protons of the methyl group of ethanol, there are three possible spin orientations
for the protons in the adjacent methylene group. These spin orientations correspond to
different energy levels and using the Larmor frequency (1) leads to three different magnetic
fields or energy levels. Nuclei in adjacent groups interact with these energy levels. The
interaction affects the methyl protons by splitting their single resonance frequency into three
resonance frequencies, which correspond to the three energy levels or orientations of the
adjacent methylene group, with which they can interact once they have absorbed energy.
This produces three resonance peaks observed in the frequency spectrum for the methyl
protons of ethanol. Peak area ratios of 1 : 2 : 1 are caused by the three possible spin
orientation interactions for the methylene protons. The middle resonance is double the
intensity of the two side resonances, because there are twice as many spin combinations with
the same total energy that produces this state. Similarly, the methylene resonance is split
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into four resonant frequency peaks by the four spin arrangements possible for the protons
on the neighboring methyl group. The relative peak area intensities of the four methylene
resonances are in the ratio of 1 : 3 : 3 : 1 because of the spin orientation arrangement of the
methyl protons.
In addition, the methyl and methylene proton resonances are 180◦ out of phase with
respect to each other. This is the result of the pulse sequence used to acquire the spectra.
Out-of-phase resonances in homonuclear spin-coupled multiplets are a characteristic feature
when spin echo pulse sequences are used to obtain the spectra and depend on this tau-value.
This out-of-phase effect is caused by changes in the spin states of homonuclear spin-coupled
systems when a 180◦ pulse is used.
Presently, the clinical significance of the spin-spin coupling phenomenon is limited to the
identification of lactate in several pathologic processes [30]. However, when clinical facilities
with higher field magnets begin to perform more in vivo MRS on patients, spin-spin cou-
pling will become more relevant in the identification of important metabolites, because the
higher resolution of these systems allows separation of overlapping resonances [16]. In addi-
tion, preliminary in vivo human brain studies using two-dimensional correlated spectroscopy
techniques at 1.5 T have been performed [32]. This technique examines nuclei that are spin
coupled and increases the ability to identify other important proton metabolites.
2.2.4 Quantification of Chemical Shifts
Chemical shifts are usually measured relative to the peak position of an arbitrary reference
compound or the center Larmor carrier frequency of the spectrometer for nuclei at the field
strength being used. In the case of in vivo brain proton MRS, N -acetylaspartate (NAA) is
normally chosen as the internal reference compound and is set at 2 ppm in the spectrum.
The frequency position of this resonance is separated by a factor of 2ppm from the center
radiofrequency of the spectrometer.
In practice, when displaying spectra, the frequencies are not expressed in absolute units,
e.g. Hertz. If the chemical shift is reported in Hertz, then the chemical shift would depend
on the magnetic field. It is preferable to refer to the chemical shift as a relative value δ
and to define it as the frequency separation between the resonance peak and the reference
Larmor frequency for the nuclei under investigation divided by the operating spectrometer
frequency or the magnetic field B0:
δ = (Bi −Bref )/B0 × 10
−6 = (ωi − ωr)/ω0 × 10
−6 (2)
where Bi and ωi are the radiofrequency and magnetic field at which resonance occurs for
the nuclei being described, and B0 and ω0 are the magnetic field and the center Larmor
radiofrequency of the nuclei under investigation (for protons at 1.5 T, this value is 63.86
6
mHz; for phosphorus at 1.5 T, it is 25.85 mHz). δ is dimensionless and is measured in parts
per million. The ppm unit is used because the resonance frequency is in megahertz (106 Hz),
but the difference between the reference peak and the compound peak is only a few hertz.
Therefore, this ratio is on the order of 10−6, or parts per million. Multiplication by 106
produces a more convenient δ number (between 0 and 10 ppm for protons). The significance
of δ is that chemical shift positions of the nuclei with the same atomic number measured in
ppm are independent of the field strength used.
2.3 Proton Spectroscopy MRI
Protons are widely used for MRS because of their high natural abundance in organic sub-
stances and high nuclear magnetic sensitivity, especially compared to phosphorus [6]. In
addition, diagnostically resolvable hydrogen MR spectra may be obtained with existing MR
units (≥ 1.5 T) and standard head coils [6]. Typically, investigators evaluate for changes in
levels of N -acetylaspartate (NAA), choline (Cho), and creatine (Cr). Early studies looking
at brain tumors and cerebral infarctions have validated the use of 1H MRS in the evaluation
of neurological abnormalities.
Recent and preliminary reports for single-volume 1H MRS show promising but variable
results in the evaluation of mesial temporal lobe seizures [7, 8, 10, 12]. Most of these studies
demonstrate a decrease in the NAA and NAA:Cr ratio or in the NAA and NAA:(Cho+Cr)
ratio [7, 10, 12], while others have reported only low concentration of NAA without the
changes in the levels of Cr and Cho [11, 13]. Increases in Cr and Cho have, however, also
been reported [8, 12]. Common to all 1H MRS studies is the decrease in NAA in the affected
temporal lobes of intractable epilepsy patients compared to normal controls. Reduction in
NAA may be interpreted as neuronal loss or damage, a frequent in vitro 1H MRS finding
when examining seizure foci [17]. This finding is supported by pathologic studies that have
shown that there is extensive neuronal loss and reactive astrocytosis in the affected HC and
in the adjacent temporal lobe. The magnitude of the decrease in NAA is too great to be
explained by loss or damage to only the mesial temporal neurons and likely reflects the
widespread damage in the adjacent regions of the temporal lobe [17]. This may explain the
abnormalities detected on MRS studies in which the volume of interest (VOI) encompassed
far more than just the HC. Therefore, despite the integration of normal-appearing tissues
into a VOI, partial volume artifacts may not be significant in patients with hippocampal
seizures. It is likely that the changes in the aforementioned ratios merely reflect a decrease
in NAA and are unrelated to Cr and Cho. Some researchers have chosen not to use Cr or
Cho ratios in spectral analysis because, when the metabolic values are expressed as ratios,
it is often impossible to determine what the findings reflect [28].
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2.4 Two-dimensional Correlated Spectroscopy
One-dimensional proton magnetic resonance spectroscopy (NMRS) is a highly sensitive tech-
nique that permits the detection of numerous metabolites in living tissues under normal and
pathologic conditions. However, the chemical shift range of proton spectra is relatively nar-
row, which leads to overlapping resonances. This overlap makes the assignment of resonances
to specific protons difficult. In clinical applications of NMRS, the problem of overlapping
resonances may be more severe due to broadening of the spectral peaks and the complexity
of spectra of cells and tissues [5].
Two-dimensional NMR methods can be employed to separate the composite 1-D spectral
MRS resonances into their component peaks by the generation of cross-peaks in a second
dimension. These cross-peaks provide information necessary for the identification of addi-
tional metabolites that are not visible in the one-dimensional spectrum. Thus, 2-D NMR
has the potential for providing useful information in the clinical environment beyond that
currently available through 1-D proton NMR.
The basic 2-D NMR sequence, scalar correlated spectroscopy (2-D COSY), provides a
technique for identifying metabolites by identifying protons that are spin-coupled [15, 25].
Spin-coupling results from the different environments generated by interactions between the
hydrogen atoms within a molecule. The spinning of a proton generates a magnetic moment
along the axis of the spin, caused by the spinning charge. This results in a local magnetic
field around each proton. The interactions between the local magnetic fields of adjacent
protons alter the effective field strength that the proton “feels.” The effective field strength
of a proton may be slightly increased or decreased, depending on whether the neighboring
proton is aligned with or against the applied field at any given instant. This change in
effective field strength changes the frequency at which the proton absorbs energy, resulting
in spin-spin splitting, since the spin of one nucleus causes a change in the energy levels of a
nearby nucleus.
The result of the 2-D COSY sequence is a two-dimensional plot that contains a series of
cross-peaks. Figure 4 shows a 2-D COSY contour plot of lactic acid. These off-diagonal cross-
peaks show which resonances on the diagonal are scalar-coupled, allowing the resonances to
be assigned to specific molecules or compounds [9, 19, 21].
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Figure 4: 2-D COSY contour plot of lactic acid demonstrating a two-dimensional plot with
symmetric cross peaks that represent scalar-coupled resonances of lactic acid.
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3 Previous Work
2-D NMR has been used to evaluate cells and tissue to identify resonances that were not
resolvable using 1-D proton NMR. For example, Mountford et al. [21] used detailed infor-
mation on the lipid resonances obtained through 2-D NMR techniques to detect changes in
cellular chemistry that occur during the transformation of normal cells to neoplastic cells
and in the progression of malignant disease. The additional resonances allowed them to dis-
criminate between control, immunostimulated, and tumor-bearing lymph nodes from rates.
Specifically, the tumor-bearing nodes had more intense cross-peaks of lactate, choline, fucose,
and amino acids than did the normal or immunostimulated node.
In a study of human cells, Lean et al. [15] demonstrated the use of 2-D proton MRS
for distinguishing between a highly tumorigenic human malignant colorectal cell line and a
lowly tumorigenic cell line of similar origin. An altered lipid profile, higher choline metabolite
content, and more complex cell surface fucosylation allowed the discrimination of the highly
tumorigenic cells from the less tumorigenic cells. Mackinnon et al. [18] further developed
this distinction, providing a correlation between an increase in the complexity of cell surface
fucosylation and cellular differentiation in a well-defined series of adenoma and carcinomal
colorectal cell lines and tissues.
Lean et al. [16] reported the ability to assess the cellular dedifferentiation using MRS
profiles of colorectal tissues and to discriminate between tumor and normal colorectal mucosa.
They also reported that the spectral patterns identified two categories within the normal
mucosa, one of which had some of the MR characteristics of malignancy, specifically the
appearance of cross-peaks from bound fucose. They suggest that these findings may indicate
a mechanism for characterizing abnormal nonmalignant colorectal tissues with proton MRS.
They further suggest that these findings may contribute to the understanding of the process
of transformation of tissues from normal to malignant state.
High-resolution proton NMR studies of intact cancer cells also has provided information
on differences between cells with the capacity to metastasize and those that produce locally
invasive tumors. Mountford et al. [20] used high-resolution NMR to asses the metastatic
potential of primary tumors. They demonstrated that the component resonances in the
lipid methylene region at 1.2 ppm could provide information on the biologic status of intact
cancer cells. They concluded that the ability of cells to metastasize might be attributed
in part to cell membrane characteristics, which are determined in part by the modulating
effects of the plasma membrane lipids. NMR resonances that characterized the metastatic
cells were associated with an increased ratio of cholesterol to phospholipid and an increased
amount of plasma membrane-bound cholesterol ester. This was supported by the work of
Sivaraja et al. [27] in a study of smooth muscle tumors (leiomyosarcoma) and benign tissues
(leiomyoma) that evaluated the relationship between metastatic potential and differences in
triglycerides and carbohydrates information from the NMR spectra. May et al. [19] and
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Williams et al. [33] used high-resolution 2-D NMR to further analyze cell suspensions to
identify these resonances as arising predominantly from triglyceride in the plasma membranes
and from soluble nonlipid components. This increase in the relative amounts of neutral
lipid-triglyceride in the membrane may result in changes in the permeability properties of
the membranes.
Mukherji et al. [23] evaluated the use of 2-D COSY in the analysis of tissue specimens
of human squamous cell carcinomas of the extracranial head and neck. The goal was to
ascertain which cross-peaks in the 2-D COSY spectra could be used to discriminate between
tumor and normal tissues. Data were analyzed for the presence or absence of the cross-peaks
for choline, phosphocholine, glycerophosphocholine, alanine, glycine, glutamine, histidine,
leucine, isoleucine, valine, inositol, taurine, lactate, triglycerides A-G, fucose-threonine, and
lysine-polyamine. Chi-square analysis indicated that the cross-peaks for alanine, glutamine,
histidine, isoleucine, valine, and lysine-polyamine were more likely to be detected in tumor
samples than in normal tissues. The spectra generated from tumor tissue were considerably
more complex than those from normal tissue and contained lipid peaks that were smaller
and less elliptical than those in normal tissue spectra.
2-D NMR has also been used in vivo to resolve resonances that overlap in the 1-D
spectra. This was demonstrated by Sotak et al. [29], who employed 2-D NMR to distinguish
between lipid and lactate in a localized volume, using a surface coil over Radiation Induced
Fibrosarcoma-1 (RIF-1) tumors implanted subcutaneously on the back of a mouse. Peres et
al. [24] measured the total glucose pool in rat brains by 2-D NMR using a surface coil. The
surface coil was placed directly on the skull of a rat. They reported a linear relationship
between cross-peak volume and concentration but could not measure absolute concentrations
because of the lack of an internal reference. The 2-D spectra also allowed resolution of the




The human brain is an example of a biological neural network. It contains many billions of
cells known as nerve cells or neurons. These cells are organized into a complex intercom-
municating network. Each neuron is physically connected to tens of thousands of others.
Using these connections, neurons pass electrical signals to one another. These connections
are not merely on or off; they have varying strength, allowing the influence of a given neuron
on its neighbors to be very strong, very weak, or anywhere in between. Furthermore, many
aspects of brain function (particularly the learning process) are closely associated with the
adjustment of these connection strengths. Brain activity, then, is represented by particular
patterns of firing activity among this network of neurons. This simultaneous cooperation
among a myriad of simple processing units is the basis of the enormous sophistication and
computational power of the brain.
An artificial neural network (ANN) is a computational model whose architecture is mod-
eled after the brain. It consists of many simple processing units which are connected together
in a complex communication network [1]. In most cases an ANN is an adaptive system whose
structure changes based on information flowing through the network. This allows ANNs to
be “trained” to solve certain types of problems. In this way, ANNs have shown themselves
to be quite effective at classification problems, including pattern and sequence recognition
and novelty detection.
The most basic ANN has three layers, including a layer of input neurons and a layer of
output neurons. More complex systems are possible, with more layers, and various “weights”
assigned to each processing unit, which manipulates the data in the calculations.
The ability of an ANN to learn is what makes them especially powerful. Given a specific
problem, and a class of functions F , an ANN can “learn” by using a set of observations to
find the function f ∗ ∈ F , an optimal solution to the problem.
This optimal solution is can be defined by specifying a cost function C : F → R such
that, for the optimal solution f ∗, C(f ∗) ≤ C(f)∀f ∈ F . That is to say, no alternate solution
has a cost less than that of the optimal solution.
4.2 Methodology
It is with this in mind that we intend to differentiate causes of edema within the bones
of the foot. One of the most common causes of such edema is arthritis. Also common is
osteomyelitis, an infection of the bone or bone marrow.
We shall use artificial neural networks to test the hypothesis that there is a significant
difference in pH between infected bone edema and non-infected edema, as seen in Charcot’s
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joint, which can be detected via MR Spectroscopy. This is a novel approach to solving the
diagnosis problem, as it is based on a fundamentally different method of differentiating the
causes of edema than those traditionally used.
For our ANN, the function f(x) by which we will evaluate metabolite levels is defined as





where K is a function measuring the metabolite level of the input spectroscopy data.
In order to make this determination, we require MR Spectroscopic data on a number
of patients, where the determination of whether each patient’s data represents infected or
non-infected edema has already been made by a pathologist. One problem that often plagues
studies of this sort is that of insufficient data. Ideally, one would like to have a large statistical
sample to experiment with. Often, a large amount of data is difficult or impossible to come
by; one simply has to do the best he can with the data available.
To circumvent this problem, we can use one-half of this data set to “train” our ANN to
make the determination between infected bone edema and non-infected edema. This will
allow us to then use the trained ANN on the remaining data. We measure the metabolite
level of the input spectroscopy data, using that information as the input into our evaluation
function, so that the value given by f ultimately predicts the cause of edema in a given case,
which we expect will match the determination already made by the pathologis. By comparing
it to this previously-made determination, we can gauge the accuracy of this trained ANN,
illustrating the rate of success with which it can be used to differeniate the two different
causes of edema within the bones of the foot.
Depending on this rate of success, our ANN’s training can be further refined by using
the second half of the data set as a second training set. The results of this additional
training can be evaluated by using it to make the edema cause determination, and again
comparing the results to those determined by the traditional method. The data can then be
further re-arranged, using a different subset each time for training, making predictions about
the remaining data based on that training. It is our assertion that this design will prove
succesful, demonstrating that a sufficiently-trained ANN can indeed be used to differentient
the causes of edema within the bones of the foot. If this is the case, it should prove a valuable




There are over 5,000 hospitals operating in the United States [3], supporting approximately
3,000 radiology practices [31]. With approximately 1 in 62 people suffering from edema [2],
there are myriad opportunities to improve the diagnosis of its causes. By developing a robust
diagnostic tool, this evaluation could be made quicker and more efficient, and thanks to the
refinement of ANNs, with great accuracy.
With thousands of radiology departments performing numerous such diagnoses, this ap-
proach has the potential to produce great savings in time and resources, and to contribute
to the health and well-being of patients sufferent from edema.
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